 And you are likely going to get burned. Well, apparently almost 9 out of 10 patients on the blockbuster weight loss drugs that I'm talking about here, these GLP-1 agonist drugs like Osambic and Wegovy and all these other ones, they're quitting them early. That's what a new analysis shows.